Online citations, reference lists, and bibliographies.
← Back to Search

Benign Prostatic Hyperplasia In An Unselected Community-based Population: A Survey Of Urinary Symptoms, Bothersomeness And Prostatic Enlargement.

R. Simpson, W. Fisher, A. J. Lee, E. B. Russell, M. Garraway
Published 1996 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
OBJECTIVES To determine the prevalence of (anatomical) benign prostatic hyperplasia/enlargement (BPH/BPE) in an unselected population and to assess the relationships between BPE, urinary flow rates (UFRs) and symptoms in men with BPH. SUBJECTS AND METHODS All men aged 40-79 years and living in three ex-mining villages in Scotland were invited to undergo a measurement of UFR, transrectal ultrasonography (TRUS) and to complete a symptom score and a previously validated lifestyle questionnaire. RESULTS Of 597 eligible men, 367 (61%) completed the urinary symptom questionnaire and 310 (52%) underwent TRUS and measurement of UFR. The response rate in the age group 50-69 was > 60%. Age-specific prevalence rates for BPE (prostate size > 20 g) per 1000 men were: 40-49 years, 615; 50-59 years, 776; 60-69 years, 892; and 70-79 years, 889, giving an overall rate for all ages of 765. There was no significant relationship between prostate size and symptoms, nor between size and peak UFR, nor any clear association between size and interference with activities of daily living. However, men with a UFR of > 20 mL/s were very unlikely to have prostates > 40 g. Relationships were found between some urinary symptoms and UFR. Age, weight and the level of prostate-specific antigen (PSA) were the only independent variables associated with prostate size. CONCLUSION Compared to published studies, BPE was substantially more prevalent than assumed previously. This study further reinforces the need for the subtle and detailed evaluation of patients who have a syndrome of BPH in assigning them to intervention, be it medical or surgical, or non-intervention/watchful waiting.
This paper references

This paper is referenced by
The immediate postoperative outcome of patients undergoing prostatectomy for benign prostatic hyperplasia at Kenyatta National Hospital
D. Kiptoon (2004)
Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study.
N. V. van Exel (2006)
Doxazosin modifies serotonin-mediated rabbit urinary bladder contraction
M. Khan (2000)
Who Should Be Treated and How? Evidence-Based Medicine in Symptomatic BPH
M. Speakman (1999)
Up‐regulation of endothelin‐B (ETB) receptors and ETB receptor‐mediated rabbit detrusor contraction in partial bladder outlet obstruction
Khan (1999)
Analysis of the Results Obtained with a new Phytotherapeutic Association for Benign Prostatic Hyperplasia versus Controls
E. Bercovich (2010)
Physical activity and benign prostatic hyperplasia.
E. Platz (1998)
Longitudinal Study on Occurrence and Prognosis of Male Lower Urinary Tract Symptoms
A. Pöyhönen (2014)
Benign prostatic hyperplasia
R. Kirby (1999)
Patient characteristics and treatment patterns for patients with benign prostatic hyperplasia, erectile dysfunction or co‐occurring benign prostatic hyperplasia and erectile dysfunction in general practices in the UK: a retrospective observational study
D. Ilo (2015)
α1-Blocker Therapy for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: What Are the Relevant Differences in Randomised Controlled Trials?
C. Mey (2000)
Screening and Diagnostic Considerations in Benign Prostatic Hyperplasia
N. Bryan (1997)
Fluid intake and urinary bladder cancer.
M. Allam (2005)
Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project.
G. Schatzl (2000)
Incidence, prevalence and management of lower urinary tract symptoms in men in the UK
J. Logie (2005)
How Do Symptoms Indicative of BPH Progress in Real Life Practice? The UK Experience
G. Clifford (2000)
Evaluation clinique des dispositifs médicaux
L. Huot (2012)
Physiotherapy for Male Continence Problems
G. Dorey (1998)
The lipidosterolic extract ofSerenoa repens in the treatment of benign prostatic hyperplasia: A comparison of two dosage regimens
X. Giannakopoulos (2002)
Estimating a population's needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need?
J. Treagust (2001)
The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis
S. Lee (2017)
Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia.
E. Platz (1999)
Efficacy and safety of a combination of sabal and urtica extract in lower urinary tract symptoms. A randomized, double-blind study versus tamsulosin.
U. Engelmann (2006)
Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study.
E. Platz (2000)
Pathophysiological relationships between lower urinary tract symptoms and the prostate do not strengthen over time
A. Lee (1998)
Relief of BPO or Improvement in Quality of Life?
P. Teillac (1998)
Prevalence of Benign Prostatic Hyperplasia (BPH) in Saudi Patients above 40 Years Old
Markhan Hammad Almarkhan (2018)
Health related quality of life in older men without prostate cancer.
M. Litwin (1999)
Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction – Triumph: The Role of General Practice Databases
J. Logie (2001)
Evaluation of Lower Urinary Tract Symptoms of Outpatients with Prostatic Disease: The Relationship among UFM, TRUS, and IPSS and QOL Score.:THE RELATIONSHIP AMONG UFM, TRUS, AND IPSS AND QOL SCORE
K. Suzuki (1997)
The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate.
M. Kojima (1997)
A clinical overview of the treatment of post-prostatectomy incontinence.
G. Dorey (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar